THERANOSTICS IN
PROSTATE CANCER

March 25, 2022

 

 

07h00-07h50 Registration                                              
 
Opening Session by the Scientific Committee
THERANOSTICS IN PROSTATE CANCER
08h00-08h10
Elba Etchebehere Allan Santos Celso Dario Ramos Mariana Lima
Ubirajara Ferreira André Moraes Wagner Matheus André Sasse
 
PROSTATE CANCER I
Primary staging 
Moderadores Allan Santos, UNICAMP e MND Wagner Matheus, UNICAMP Antonio Zuliani de Oliveira, UNICAMP
08h10-08h30 How does nuclear medicine imaging impact patient management by the urologist? Ubirajara Ferreira, UNICAMP
08h30-08h50 Bone SPECT/CT? Fluoride-18F PET/CT? PSMA PET/CT? Which, when, and how? Sérgio Almeida, Rede D´Dor, RJ
08h50-09h00 PET/CT with PSMA-68Ga versus PET/CT with PSMA-18F Camila Mosci, Hospital Vila Nova Star, SP
09h00-09h20 PET PSMA in primary staging: when and why? Onófrio Catalano, Massachussets General Hospital, USA
09h20-09h35 Interactive Session: Take Home Message with clinical case discussion 
PSMA PET in primary staging Presenter Dalton Anjos, DASA, SP
Debater Wagner Matheus, UNICAMP
09h35-09h45 Comments and questions from audience and moderators 
 
09h45-10h10 Coffee Break
 
PROSTATE CANCER II
Diagnosis in biochemical recurrence and treatment response evaluation
Moderadores Elba Etchebehere, UNICAMP e MND  Ubirajara Ferreira, UNICAMP Carlos Monti, Instituto do Radium
10h10-10h30 How does nuclear medicine imaging impact patient management by the oncologist? André Moraes, Centro de Oncologia Campinas
10h30-10h45 PET PSMA biochemical recurrence – when and why? Onófrio Catalano, Massachussets General Hospital, USA
10h45-11h10 PET/CT PSMA in treatment response evaluation. Advantages and limitations: is it worth it? Mike Sathekge, University of Pretoria
11h10-11h20 Cross fire: should I use PSMA PET to plan radiotherapy?  Yes Eduardo Baldon, UNICAMP
No Antônio Zuliani, UNICAMP
11h20-11h40 Interactive Session: Take Home Message with clinical case discussion
PSMA PET/CT Pitfalls Presenter Marcus Grigolon, Sírio Libanês, Brasília
Debater Júlio Prestes, Hospital Sírio Libanês, SP
PSMA PET in biochemical recurrence Presenter Marcelo Livorsi, Hospital Albert Einstein
Debater Helena Saito, UNICAMP
11h40-12h00 Comments and questions from audience and moderators 
 
12h00-13h30 Lunch break

 

PROSTATE CANCER  III
Therapy with radiolabeled PSMA
Moderadores Mariana Lima, UNICAMP e MND Fernandes Denardi, UNICAMP André Moraes, Centro de Oncologia Campinas
13h30-13h50 PSMA PET/CT in oligometastatic disease Elba Etchebehere, UNICAMP e MND 
13h50-14h00 PSMA PET/CT to define strategies and systemic treatment sequencing.  André Sasse, SonHe
14h00--14h30 Clinical results of therapy with PSMA-177Lu/225Ac Mike Sathekge, University of Pretoria, África do Sul
14h30-14h50 Interactive Session: Take Home Message with clinical case discussion
Therapy with 177Lu-PSMA and 225Ac-PSMA Presenter Mike Sathekge, University of Pretoria, África do Sul
Debater André Moraes, Centro de Oncologia Campinas
14h50--15h00 Comments and questions from audience and moderators 
 
15h00-15h30 Lunch break
 
PROSTATE CANCER IV
Therapy with 223Ra
Moderadores Celso Dario Ramos, UNICAMP e MND Helena Saito, UNICAMP Leonardo Reis, UNICAMP
15h30-15h50 223Ra therapy: when to indicate? The nuclear medicine physician's perspective.  Flavia Lopes, Instituto Vilella-Pedras, RJ
15h50-16h10 Controversies, interruption and re-treatment with  223Ra   Letícia Rigo, Beneficiência Portuguesa, SP
16h10-16h40 Interactive Session: Take Home Message with clinical case discussion
Monotherapy with 223Ra Presenter Letícia Rigo, Beneficiência Portuguesa, SP
Debater Helena Saito, UNICAMP
Combine therapy with  223Ra Presenter George Coura, USP
Debater Leonardo Reis, UNICAMP
16h40-16h50 Comments and questions from audience and moderators 
 
19h30-23h30  Symposium Celebration -  Esquinica Vitória Hotel